Skip to main content
Top
Published in: Intensive Care Medicine 7/2011

01-07-2011 | Original

Severity of ICU-acquired pneumonia according to infectious microorganisms

Authors: Pierre Damas, Nathalie Layios, Laurence Seidel, Monique Nys, Pierrette Melin, Didier Ledoux

Published in: Intensive Care Medicine | Issue 7/2011

Login to get access

Abstract

Purpose

To assess the severity of intensive care unit (ICU)-acquired pneumonia (ICUAP) according to the bacteria involved, classified into seven groups: third-generation cephalosporin-resistant non-fermenting Gram-negative bacilli (resistant C3NF); sensitive C3NF; methicillin-resistant Staphylococcus aureus; methicillin-sensitive Staphylococcus aureus; extended-spectrum beta-lactamase-producing Enterobacteriaceae; Enterobacteriaceae not producing extended-spectrum beta-lactamase; Haemophilus influenzae and Streptococcus pneumoniae.

Methods

Over a 4-year period, sequential organ failure assessment (SOFA) score was prospectively measured daily in 453 adult patients with ICUAP. ICUAP severity was evaluated by the severity of sepsis and by the occurrence of new organ dysfunctions or failures (OD/F) during ICUAP.

Results

Septic shock occurred in 21% of all cases of ICUAP. The occurrence of new OD/F during ICUAP was similar regardless of the identified microorganism. These new OD/F represented less than 11% of SOFAmax, defined as the sum of all OD/F occurring at any time during the ICU stay. There was a significant association between SOFApreICUAP, defined as the sum of all the OD/F occurring before ICUAP, and ICUAP severity. In the multivariate analysis, the type of bacteria was not a risk factor (RF) for occurrence of septic shock and mortality. Age and SOFApreICUAP were RF for the sepsis severity. The ICUAP severity was an RF for ICU mortality.

Conclusions

ICUAP was responsible for a minor proportion of OD/F occurring during the ICU stay. Severity of ICUAP was related to clinical status prior to ICUAP, but not to the type of bacteria. ICU mortality depended on the severity of ICUAP.
Literature
1.
go back to reference Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644PubMedCrossRef Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, Wolff M, Spencer RC, Hemmer M (1995) The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 274:639–644PubMedCrossRef
2.
go back to reference Jiménez P, Torres A, Rodríguez-Roisin R, de la Bellacasa JP, Aznar R, Gatell JM, Agustí-Vidal A (1990) Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Resp Dis 142:523–528PubMed Jiménez P, Torres A, Rodríguez-Roisin R, de la Bellacasa JP, Aznar R, Gatell JM, Agustí-Vidal A (1990) Incidence, risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Resp Dis 142:523–528PubMed
3.
go back to reference Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C (1996) Nosocomial pneumonia and mortality among patients in intensive care unit. JAMA 275:866–869PubMedCrossRef Fagon JY, Chastre J, Vuagnat A, Trouillet JL, Novara A, Gibert C (1996) Nosocomial pneumonia and mortality among patients in intensive care unit. JAMA 275:866–869PubMedCrossRef
4.
go back to reference Kollef MH, Silver P, Murphy DM, Trovillion E (1995) The effect of late-onset ventilator associated pneumonia in determining patient mortality. Chest 108:1655–1662PubMedCrossRef Kollef MH, Silver P, Murphy DM, Trovillion E (1995) The effect of late-onset ventilator associated pneumonia in determining patient mortality. Chest 108:1655–1662PubMedCrossRef
5.
go back to reference Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281–288PubMedCrossRef Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281–288PubMedCrossRef
6.
go back to reference Kollef MH, Bock KR, Richards RD, Hearns ML (1995) The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 122:743–748PubMed Kollef MH, Bock KR, Richards RD, Hearns ML (1995) The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 122:743–748PubMed
7.
go back to reference Damas P, Ledoux D, Nys M, Monchi M, Wiesen P, Beauve B, Preiser JC (2008) Intensive care unit acquired infection and organ failure. Intensive Care Med 34:856–864PubMedCrossRef Damas P, Ledoux D, Nys M, Monchi M, Wiesen P, Beauve B, Preiser JC (2008) Intensive care unit acquired infection and organ failure. Intensive Care Med 34:856–864PubMedCrossRef
8.
go back to reference Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMedCrossRef Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMedCrossRef
9.
go back to reference McCabe WR, Jackson GG (1962) Gram-negative bacteremia, aetiology and ecology. Arch Intern Med 110:845–853 McCabe WR, Jackson GG (1962) Gram-negative bacteremia, aetiology and ecology. Arch Intern Med 110:845–853
10.
go back to reference Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, Pneum A, Trial Group (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598PubMedCrossRef Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, Pneum A, Trial Group (2003) Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 290:2588–2598PubMedCrossRef
11.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef American College of Chest Physicians/Society of Critical Care Medicine (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
12.
go back to reference Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707–710PubMedCrossRef
13.
go back to reference Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis Related Problems of the ESICM. Intensive Care Med 25:686–696PubMedCrossRef Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S (1999) The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis Related Problems of the ESICM. Intensive Care Med 25:686–696PubMedCrossRef
14.
go back to reference Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR, European Sepsis Group (2003) Influence of systemic inflammatory response syndrome and sepsis outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84PubMedCrossRef Alberti C, Brun-Buisson C, Goodman SV, Guidici D, Granton J, Moreno R, Smithies M, Thomas O, Artigas A, Le Gall JR, European Sepsis Group (2003) Influence of systemic inflammatory response syndrome and sepsis outcome of critically ill infected patients. Am J Respir Crit Care Med 168:77–84PubMedCrossRef
15.
go back to reference Brown DF, Andrews J, King A, MacGowan AP (2000) Detection of extended-spectrum beta-lactamases with Etest and double disc potentialisation methods. J Antimicrob Chemother 46:327–328PubMedCrossRef Brown DF, Andrews J, King A, MacGowan AP (2000) Detection of extended-spectrum beta-lactamases with Etest and double disc potentialisation methods. J Antimicrob Chemother 46:327–328PubMedCrossRef
16.
go back to reference American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef American Thoracic Society; Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef
17.
go back to reference Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903PubMed Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903PubMed
18.
go back to reference Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis Occurrence in Acutely Ill Patients Investigators (2006) Sepsis in European intensive units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D, Sepsis Occurrence in Acutely Ill Patients Investigators (2006) Sepsis in European intensive units: results of the SOAP study. Crit Care Med 34:344–353PubMedCrossRef
19.
go back to reference Lisboa T, Diaz E, Sa-Borges M, Socias A, Sole-Violan J, Rodríguez A, Rello J (2008) VAP-PIRO: a tool for predicting ICU mortality and health care resources use in ventilator-associated pneumonia. Chest 134:1208–1216PubMedCrossRef Lisboa T, Diaz E, Sa-Borges M, Socias A, Sole-Violan J, Rodríguez A, Rello J (2008) VAP-PIRO: a tool for predicting ICU mortality and health care resources use in ventilator-associated pneumonia. Chest 134:1208–1216PubMedCrossRef
20.
go back to reference Nguile-Makao M, Zahar JR, Français A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, Goldgran-Toledano D, Azoulay E, Adrie C, Jamali S, Clec’h C, Souweine B, Timsit JF (2010) Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 36:781–789PubMedCrossRef Nguile-Makao M, Zahar JR, Français A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, Goldgran-Toledano D, Azoulay E, Adrie C, Jamali S, Clec’h C, Souweine B, Timsit JF (2010) Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models. Intensive Care Med 36:781–789PubMedCrossRef
21.
go back to reference Klompas M (2009) The paradox of ventilator-associated pneumonia prevention measures. Crit Care 13:315PubMedCrossRef Klompas M (2009) The paradox of ventilator-associated pneumonia prevention measures. Crit Care 13:315PubMedCrossRef
22.
go back to reference Clinel I, Opal SM (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37:291–304CrossRef Clinel I, Opal SM (2009) Molecular biology of inflammation and sepsis: a primer. Crit Care Med 37:291–304CrossRef
23.
go back to reference Carlet J, Cohen J, Calandra T, Opal SM, Masur H (2008) Sepsis: time to reconsider the concept. Crit Care Med 36:964–966PubMedCrossRef Carlet J, Cohen J, Calandra T, Opal SM, Masur H (2008) Sepsis: time to reconsider the concept. Crit Care Med 36:964–966PubMedCrossRef
24.
go back to reference Melsen WG, Rovers MM, Bonten MJM (2009) Ventilator associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 37:2709–2710PubMedCrossRef Melsen WG, Rovers MM, Bonten MJM (2009) Ventilator associated pneumonia and mortality: a systematic review of observational studies. Crit Care Med 37:2709–2710PubMedCrossRef
25.
go back to reference Leroy O, Meybeck A, d’Escrivan T, Devos P, Kipnis E, Georges H (2003) Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 29:2170–2173PubMedCrossRef Leroy O, Meybeck A, d’Escrivan T, Devos P, Kipnis E, Georges H (2003) Impact of adequacy of initial antimicrobial therapy on the prognosis of patients with ventilator-associated pneumonia. Intensive Care Med 29:2170–2173PubMedCrossRef
26.
go back to reference Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulmé R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMedCrossRef Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulmé R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMedCrossRef
27.
go back to reference Brun-Buisson C, Meshaka P, Pinton P, Vallet B, EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30:580–588PubMedCrossRef Brun-Buisson C, Meshaka P, Pinton P, Vallet B, EPISEPSIS Study Group (2004) EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30:580–588PubMedCrossRef
28.
go back to reference Lisboa T, Rello J (2008) Diagnosis of ventilator-associated pneumonia: Is there a gold standard and a simple approach? Curr Opin Infect Dis 21:174–178PubMedCrossRef Lisboa T, Rello J (2008) Diagnosis of ventilator-associated pneumonia: Is there a gold standard and a simple approach? Curr Opin Infect Dis 21:174–178PubMedCrossRef
29.
go back to reference Niederman M (2010) The argument against using quantitative cultures in clinical trials and for the management of ventilator-associated pneumonia. Clin Infect Dis 51:593–599 Niederman M (2010) The argument against using quantitative cultures in clinical trials and for the management of ventilator-associated pneumonia. Clin Infect Dis 51:593–599
30.
go back to reference The Canadian Critical Care Trials Group (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355:2619–2630CrossRef The Canadian Critical Care Trials Group (2006) A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med 355:2619–2630CrossRef
31.
go back to reference Eggimann P, Hugonnet S, Sax H, Touveneau S, Chevrolet JC, Pittet D (2003) Ventilator-associated pneumonia: caveats for benchmarking. Intensive Care Med 29:2086–2089PubMedCrossRef Eggimann P, Hugonnet S, Sax H, Touveneau S, Chevrolet JC, Pittet D (2003) Ventilator-associated pneumonia: caveats for benchmarking. Intensive Care Med 29:2086–2089PubMedCrossRef
32.
go back to reference Lacherade JC, De Jonghe B, Guezennec P, Debbat K, Hayon J, Monsel A, Fangio P, Appere de Vecchi C, Ramaut C, Outin H, Bastuji-Garin S (2010) Intermittent subglottic secretion drainage and ventilator-associated pneumonia : a multicenter trial. Am J Resp Crit Care Med. 182:910–917. doi: 10.1164/rccm.200906-0838OC Lacherade JC, De Jonghe B, Guezennec P, Debbat K, Hayon J, Monsel A, Fangio P, Appere de Vecchi C, Ramaut C, Outin H, Bastuji-Garin S (2010) Intermittent subglottic secretion drainage and ventilator-associated pneumonia : a multicenter trial. Am J Resp Crit Care Med. 182:910–917. doi: 10.​1164/​rccm.​200906-0838OC
33.
go back to reference Magret M, Amaya-Villar R, Garnacho J, Lisboa T, Díaz E, Dewaele J, Deja M, Manno E, Rello J, EU-VAP/CAP Study Group (2010) Ventilator associated pneumonia in trauma patients is associated with lower mortality. Results from EU-VAP study. J Trauma 69:849–854PubMedCrossRef Magret M, Amaya-Villar R, Garnacho J, Lisboa T, Díaz E, Dewaele J, Deja M, Manno E, Rello J, EU-VAP/CAP Study Group (2010) Ventilator associated pneumonia in trauma patients is associated with lower mortality. Results from EU-VAP study. J Trauma 69:849–854PubMedCrossRef
Metadata
Title
Severity of ICU-acquired pneumonia according to infectious microorganisms
Authors
Pierre Damas
Nathalie Layios
Laurence Seidel
Monique Nys
Pierrette Melin
Didier Ledoux
Publication date
01-07-2011
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 7/2011
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-011-2255-8

Other articles of this Issue 7/2011

Intensive Care Medicine 7/2011 Go to the issue